Sanofi
Portfolio in France · United States: 3 funded startups tracked by Uback, 3 of them in a ranking.
Portfolio on Uback3startups, 2 countries
In a ranking3ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedMar 2026Earendil Labs
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Earendil Labs | #2 AI drug discovery | Healthtech › Biotech › AI drug discovery | Equity financing · USD 787M (several financing rounds) · Mar 2026 | Unicorn |
| Formation Bio | #6 AI drug discovery | Healthtech › Biotech › AI drug discovery | Series D · USD 372M · Jun 2024 | Unicorn |
| Owkin | #9 AI drug discovery | Healthtech › Biotech › AI drug discovery | Strategic equity · USD 180M · Nov 2021 | Hundreds of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12021
02022
02023
12024
02025
12026
Co-investors
Dimension · DST Global · INCE Capital · Biotech Development Fund · Andreessen Horowitz
Investors that joined the same rounds, as reported by public sources.
Sources. en.wikipedia.org, owkin.com, prnewswire.com, techcrunch.com, wewillcure.com, as cited on each company’s profile.
Last updated: Sep 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.